Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskelet… Read more
Beximco Pharmaceuticals Limited - Asset Resilience Ratio
Beximco Pharmaceuticals Limited (BXP) has an Asset Resilience Ratio of 0.95% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Beximco Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Beximco Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX700.00 Million | 0.95% |
| Total Liquid Assets | GBX700.00 Million | 0.95% |
Asset Resilience Insights
- Limited Liquidity: Beximco Pharmaceuticals Limited maintains only 0.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Beximco Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio
Compare Beximco Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
High Sierra Technologies Inc
PINK:HSTI |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
Annual Asset Resilience Ratio for Beximco Pharmaceuticals Limited (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Beximco Pharmaceuticals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.29% | GBX200.00 Million | GBX69.34 Billion | +0.05pp |
| 2023-06-30 | 0.24% | GBX166.25 Million | GBX69.16 Billion | +0.08pp |
| 2022-06-30 | 0.16% | GBX108.08 Million | GBX66.15 Billion | -0.05pp |
| 2021-06-30 | 0.22% | GBX112.83 Million | GBX52.25 Billion | +0.07pp |
| 2020-06-30 | 0.14% | GBX70.79 Million | GBX50.12 Billion | -0.52pp |
| 2019-06-30 | 0.66% | GBX323.36 Million | GBX49.21 Billion | -0.12pp |
| 2018-06-30 | 0.78% | GBX339.40 Million | GBX43.74 Billion | -1.83pp |
| 2017-06-30 | 2.60% | GBX886.58 Million | GBX34.08 Billion | -2.24pp |
| 2016-06-30 | 4.84% | GBX1.51 Billion | GBX31.15 Billion | -0.16pp |
| 2015-12-31 | 4.99% | GBX1.54 Billion | GBX30.84 Billion | -3.54pp |
| 2014-12-31 | 8.53% | GBX2.48 Billion | GBX29.00 Billion | -2.48pp |
| 2013-12-31 | 11.02% | GBX3.03 Billion | GBX27.47 Billion | +0.09pp |
| 2012-12-31 | 10.93% | GBX2.69 Billion | GBX24.59 Billion | +1.40pp |
| 2011-12-31 | 9.52% | GBX2.19 Billion | GBX23.03 Billion | +5.50pp |
| 2010-12-31 | 4.02% | GBX859.41 Million | GBX21.37 Billion | -12.06pp |
| 2009-12-31 | 16.08% | GBX3.20 Billion | GBX19.89 Billion | +15.87pp |
| 2008-12-31 | 0.21% | GBX31.13 Million | GBX14.82 Billion | -0.08pp |
| 2007-12-31 | 0.29% | GBX34.45 Million | GBX11.95 Billion | -0.02pp |
| 2006-12-31 | 0.31% | GBX37.30 Million | GBX11.91 Billion | -- |